MedPath

Evaluation of tDCS Efficacy in Enduring Anorexia Nervosa

Not Applicable
Terminated
Conditions
Anorexia Nervosa
Interventions
Device: transcranial Direct Current Stimulation (tDCS)
Registration Number
NCT03813355
Lead Sponsor
Centre Hospitalier Universitaire de Saint Etienne
Brief Summary

Approximately 20% of anorexia nervosa cases do not respond to conventional management strategies: cognitive behavioral therapy, weight gain contract, drug treatments, etc ... - whether they are applied outpatients or during very long hospitalizations. These situations of chronic evolution are characterized by a high rate of mortality. Brain stimulation could be an alternative therapy for these patients. tDCS (transcranial direct current stimulation) is a non-invasive stimulation technique that has demonstrated beneficial effects in other psychiatric conditions such as major depression or schizophrenia.

The objectives of the study will be to evaluate the efficacy of tDCS in anorexia nervosa resistant to conventional treatments on weight gain, eating behavior, psychological and nutritional behavioral scales, cognition, connectivity and brain activity.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
Female
Target Recruitment
17
Inclusion Criteria
  • Diagnostic and Statistical Manual of Mental Disorders (DSM)-5 anorexia nervosa criteria
  • Body Mass Index (BMI) < 17kg/m2
  • Conventional treatment failure over the last 12 months
  • Refusal or no indication of artificial nutrition
Exclusion Criteria
  • Artificial nutrition
  • Other chronic diseases
  • drug use (except tobacco)
  • pregnancy
  • Edinburgh score < 14

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Active stimulationtranscranial Direct Current Stimulation (tDCS)Brain stimulation by Transcranial Direct Current Stimulation (tDCS) with active stimulations
Sham stimulationtranscranial Direct Current Stimulation (tDCS)Brain stimulation by Transcranial Direct Current Stimulation (tDCS) with inactive stimulations
Primary Outcome Measures
NameTimeMethod
Body Mass Index (BMI)weeks 8

Change in body mass index after stimulation sessions. Weight and Height will be combined to report BMI in kg/m\^2

Secondary Outcome Measures
NameTimeMethod
Eating Disorder Inventory (EDI)weeks 8

Change in Eating Disorder Inventory scale after stimulation sessions

EDI measures :

* Drive for thinness (score between 0-4)

* Bulimia (score between 0-5)

* Body dissatisfaction (score between 3-10)

* ineffectiveness (score between 0-6)

* Perfectionism (score between 0-5)

* Interpersonal Distrust (score between 0-6)

* Interoceptive awareness (score between 0-4)

* Maturity Fears (score between 0-6)

State-Trait Anxiety Inventory (STAI)weeks 8

Change in State-Trait Anxiety Inventory (STAI) after stimulation sessions

STAI measures :

* no anxiety : score between 0-19

* very low anxiety : score between 36-45

* low anxiety : score between 46-55

* moderate anxiety : score between 56-65

* high anxiety : score between 56-65

* very high anxiety : score greater than 65

Dutch Eating Behavior Questionnaire (DEBQ)weeks 8

Change in Dutch Eating Behavior Questionnaire (DEBQ) after stimulation sessions

DEBQ measures :

* Restrained eating (score between 10-30)

* Emotional eating (score between 17-35)

* external eating (score between 20-40)

Beck Depression Inventory (BDI)weeks 8

Change in Beck Depression Inventory after stimulation sessions.

BDI measures :

* No depression : score between 0-9

* midl depression or anxiety : score between 10-19

* moderate depression or anxiety : score between 20-25

* moderate to severe depression or anxiety : score between 26-29

* severe depression or anxiety : score between 30-40

* very severe depression or anxiety : score between 41-84

Trial Locations

Locations (4)

CHU Grenoble

🇫🇷

Grenoble, France

CHU Saint-Etienne

🇫🇷

Saint-Etienne, France

Hospices Civils de Lyon

🇫🇷

Lyon, France

CHU Clermont-Ferrand

🇫🇷

Clermont-Ferrand, France

© Copyright 2025. All Rights Reserved by MedPath